MREO — Mereo BioPharma Cashflow Statement
0.000.00%
Last trade - 00:00- $39.72m
- -$1.27m
- $0.50m
Annual cashflow statement for Mereo BioPharma, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 20-F | 20-F | 10-K | ARS | 10-K |
| Standards: | IFRS | IFRS | USG | USG | USG |
| Status: | fx Final | fx Final | Final | Final | Final |
| Net Income/Starting Line | 19.6 | -44.5 | — | — | — |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | -29 | -4.62 | 9.36 | 10.2 | 13.5 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 1.35 | 0.36 | -31.1 | -43.6 | -45.1 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -7.2 | -47.8 | -21.1 | -32.8 | -31 |
| Capital Expenditures | -0.736 | -0.012 | -0.419 | -0.699 | -0.32 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 0.157 | 1.86 | 0 | — | 0.3 |
| Sale of Business | |||||
| Sale/Maturity of Investment | |||||
| Sale of Intangible Assets | |||||
| Change in Net Intangibles | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.579 | 1.84 | -0.419 | -0.699 | -0.02 |
| Financing Cash Flow Items | -0.322 | 0.188 | -0.444 | -0.853 | -0.199 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 107 | -0.966 | 7.97 | 46.1 | 0.327 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 97.4 | -46.8 | -10.8 | 12.4 | -28.8 |